Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes - Concepedia

Concepedia

Publication | Open Access

Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes

DOI Full Paper Access

15

Citations

13

References

2022

Year

Jonathan Hyak, Ying Huang, Kerry A. Rogers, Seema A. Bhat, Michael R. Grever, John C. Byrd, Adam S. Kittai, Dan Jones, Cecelia Miller, Jennifer A. Woyach

Hematological MalignancyOncologyNovel TherapyMedicineMalignant Blood DisorderImmunologyTherapeutic EfficacyImmune Checkpoint InhibitorPharmacotherapyImmunotherapyPharmacologyBtk InhibitionCancer Research

References

	Year	Citations

Page 1

Page 1